A double-blind trial of risperidone and haloperidol for the treatment of delirium

Psychosomatics

Volumn 45, Issue 4, 2004, Pages 297-301

  Han, Chang Su ^a   Kim, Yong Ku ^a,b  

^a Korea University College of Medicine   (South Korea)

^b Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; RISPERIDONE;

ADULT; AGED; AKATHISIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIRIUM; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MEMORIAL DELIRIUM ASSESSMENT SCALE; RATING SCALE;

EID: 3042549215     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3182(04)70170-X     Document Type: Article

References (38)

1. Lipowski ZJ: Delirium (acute confusional states). JAMA 1987; 258:1789-1792
2. Inouye SK: Delirium: a barometer for quality of hospital care. Hosp Pract (Off Ed) 2001; 36:15-16, 18
3. Strain JJ, Lyons JS, Hammer JS, Fahs M, Lebovits A, Paddison PL, Snyder S, Strauss E, Burton R, Nuber G, et al.: Cost offset from a psychiatric consultation-liaison intervention with elderly hip fracture patients. Am J Psychiatry 1991; 148:1044-1049
4. American Psychiatric Association: Practice guideline for the treatment of patients with delirium. Am J Psychiatry 1999; 156(May suppl):1-20
5. Shapiro BA, Warren J, Egol AB, Greenbaum DM, Jacobi J, Nasraway SA, Schein RM, Spevetz A, Stone JR: Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Society of Critical Care Medicine. Crit Care Med 1995; 23:1596-1600
6. Casey DE: Acute extrapyramidal syndrome, in: Contemporary Use in the Treatment of Schizophrenia. Edited by Shriqui CL NH. Washington, DC, American Psychiatric Press, 1995, pp 535-550
7. Sipahimalani A, Masand PS: Use of risperidone in delirium: case reports. Ann Clin Psychiatry 1997; 9:105-107
8. Kim KS, Pae CU, Chae JH, Bahk WM, Jun T: An open pilot trial of olanzapine for delirium in the Korean population. Psychiatry Clin Neurosci 2001; 55:515-519
9. Sipahimalani A, Masand PS: Olanzapine in the treatment of delirium. Psychosomatics 1998; 39:422-430
10. Torres R, Mittal D, Kennedy R: Use of quetiapine in delirium: case reports. Psychosomatics 2001; 42:347-349
11. Schwarz T, Masand PS: Treatment of delirium with quetiapine. Primary Care Companion J Clin Psychiatry 2000; 2:10-12
12. Leysen JE, Janssen PM, Megens AA, Schotte A: Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. J Clin Psychiatry 1994; 55(suppl 5):5-12
13. Leysen JE, Gommeren W, Eens A, de Chaffoy de Courcelles D, Stoof JC, Janssen PA: Biochemical profile of risperidone, a new antipsychotic. J Pharmacol Exp Ther 1988; 247:661-670
14. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI: Clarifying confusion: the Confusion Assessment Method. A new method for detection of delirium. Ann Intern Med 1990; 113:941-948
15. Trzepacz PT, Baker RW, Greenhouse J: A symptom rating scale for delirium. Psychiatry Res 1988; 23:89-97
16. Spitzer RL, Williams JBW, Gibbon M, First MB: The Structured Clinical Interview for DSM-III-R (SCID), I: history, rationale, and description. Arch Gen Psychiatry 1992; 49:624-629
17. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorder, 3rd ed. Revised. Washington, DC, APA 1987
18. Rosen J, Sweet RA, Mulsant BH, Rifai AH, Pasternak R, Zubenko GS: The Delirium Rating Scale in a psychogeriatric inpatient setting. J Neuropsychiatry Clin Neurosci 1994; 6:30-35
19. Breitbart W, Rosenfeld B, Roth A, Smith MJ, Cohen K, Passik S: The Memorial Delirium Assessment Scale. J Pain Symptom Manage 1997; 13:128-137
20. Inouye SK, Bogardus ST Jr, Charpentier PA, Leo-Summers L, Acampora D, Holford TR, Cooney LM Jr: A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999; 340:669-676
21. Tueth MJ: Emergencies caused by side effects of psychiatric medications. Am J Emerg Med 1994; 12:212-216
22. Schwartz TL, Masand PS: The role of atypical antipsychotics in the treatment of delirium. Psychosomatics 2002; 43:171-174
23. Al-Samarrai S, Dunn J, Newmark T, Gupta S: Quetiapine for treatment-resistant delirium. Psychosomatics 2003; 44:350-351
24. Kim KY, Bader GM, Kotlyar V, Gropper D: Treatment of delirium in older adults with quetiapine. J Geriatr Psychiatry Neurol 2003; 16:29-31
25. Breitbart W, Tremblay A, Gibson C: An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 2002; 43:175-182
26. Passik SD, Cooper M: Complicated delirium in a cancer patient successfully treated with olanzapine. J Pain Symptom Manage 1999; 17:219-223
27. Meagher DJ: Delirium: optimising management. BMJ 2001; 322:144-149
28. Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C, Corbera K, Raymond S, Lund S, Jacobson P: A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996; 153:231-237
29. Adams F, Fernandez F, Andersson BS: Emergency pharmacotherapy of delirium in the critically ill cancer patient. Psychosomatics 1986; 27:33-38
30. Kerr IB, Taylor D: Acute disturbed or violent behaviour: principles of treatment. J Psychopharmacol 1997; 11:271-277
31. Menza MA, Murray GB, Holmes VF, Rafuls WA: Decreased extrapyramidal symptoms with intravenous haloperidol. J Clin Psychiatry 1987; 48:278-280
32. Ravona-Springer R, Dolberg OT, Hirschmann S, Grunhaus L: Delirium in elderly patients treated with risperidone: a report of three cases. J Clin Psychopharmacol 1998; 18:171-172
33. Tavcar R, Dernovsek MZ: Risperidone-induced delirium. Can J Psychiatry 1998; 43:194
34. Tauscher J, Tauscher-Wisniewski S, Kasper S: Treatment of patients with delirium. Am J Psychiatry 2000; 157:1711
35. Platt MM, Breitbart W, Smith M, Marotta R, Weisman H, Jacobsen PB: Efficacy of neuroleptics for hypoactive delirium. J Neuropsychiatry Clin Neurosci 1994; 6:66-67
36. Nakamura J, Uchimura N, Yamada S, Nakazawa Y: Does plasma free-3-methoxy-4-hydroxyphenyl(ethylene)glycol increase in the delirious state? A comparison of the effects of mianserin and haloperidol on delirium. Int Clin Psychopharmacol 1997; 12:147-152
37. Pi EH, Wang AL, Gray GE: Asian/non-Asian transcultural tricyclic antidepressant psychopharmacology: a review. Prog Neuropsychopharmacol Biol Psychiatry 1993; 17:691-702
38. Pi EH: Transcultural psychopharmacology: present and future. Psychiatry Clin Neurosci 1998; 52(suppl): S185-S187